Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Clinical trial NCT00783718 · COMPLETED
Trial details
- NCT number
- NCT00783718
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-12-01
- Enrollment
- 895
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.